Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cardeon AB is an investment company founded in 2018 and based in Lund, Sweden. The firm is publicly listed on the NGM Nordic SME under the ticker CARDEO. Cardeon focuses on investing in innovative Nordic companies and startups within the fields of medical technology and life sciences. The organization completed a reverse merger with Tectona Capital AB in June 2022, which significantly expanded its portfolio and market presence.
As of now, Cardeon manages a diverse portfolio of 12 companies, primarily in the healthcare and biotech sectors. The firm aims to support the development of ideas from research results to commercial products, leveraging its expertise and extensive network to facilitate growth. Cardeon has been active in the venture capital space, with its shares listed since November 2022, and has a market capitalization of approximately 24.37 million SEK.
Cardeon AB invests in companies that have the potential to create significant changes in their respective markets on a global scale. The firm specializes in medical technology and life sciences, focusing on innovative Nordic startups. Investment strategies include providing financing, strategic investments, and access to a broad network that facilitates collaborations and assists in key recruitments. Cardeon emphasizes the importance of transforming research-driven ideas into commercial products with substantial market impact.
The firm seeks to partner with companies that demonstrate the potential for global market influence. Cardeon’s investment criteria include a minimum market value target of SEK 20 million for target companies. The organization also contributes expertise to board activities, ensuring that portfolio companies are well-supported in their growth trajectories.
Cardeon AB's portfolio includes a range of notable companies in the healthcare and biotech sectors:
To pitch to Cardeon AB, startups should visit their website at cardeon.se for guidance on the application process. It is advisable to include a comprehensive deck that outlines the business model, market opportunity, and team qualifications. While specific response time expectations are not provided, founders should anticipate a thorough review process given the firm's focus on strategic investments.
Cardeon AB has been active in the venture capital space, particularly since its shares were listed on the NGM Nordic SME in November 2022. Recent activities include investments in portfolio companies such as AcroPharma, which is developing treatments for Type 2 diabetes, and TEQCool, which is focused on financing medical devices. Additionally, Deep Light Vision has received EU grant funding for its medical imaging diagnostics.
Recent reports indicate that portfolio companies are showing clinical progress, including positive trial results and patent filings for peptide therapeutics. Cardeon continues to expand its influence in the Nordic healthcare and biotech sectors.
What are Cardeon AB's investment criteria?
Cardeon AB invests in innovative Nordic companies within the medical technology and life sciences sectors. Target companies should have the potential to create significant changes in their respective markets on a global scale, with a minimum market value of SEK 20 million.
How can startups apply or pitch to Cardeon AB?
Startups interested in pitching to Cardeon AB can visit their website at cardeon.se for more information on the application process. Specific details on pitch formats or requirements are not disclosed.
What makes Cardeon AB different from other investors?
Cardeon AB is unique in its focus on transforming research results into commercial products. The firm provides not only capital but also strategic investments, access to a broad network for collaborations, and expertise to assist portfolio companies in navigating their growth paths.
What is Cardeon AB's geographic scope?
Cardeon AB primarily invests in the Nordic region, particularly Sweden, focusing on innovative startups in healthcare and biotech sectors.
What is Cardeon AB's post-investment involvement?
Cardeon AB actively contributes expertise to board activities and assists portfolio companies with key recruitments and collaborations, ensuring they have the necessary support to succeed in their markets.
What is the size of Cardeon AB's fund or check sizes?
While specific check sizes are not disclosed, Cardeon AB engages in strategic investments that align with its mission to support innovative companies in the medical technology and life sciences sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.